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ABSTRACT This theoretical work covers structural and biochemical aspects of nucleotide binding and GDP/GTP exchange of
GTP hydrolases belonging to the family of small GTPases. Current models of GDP/GTP exchange regulation are often based
on two speciﬁc assumptions. The ﬁrst is that the conformation of a GTPase is switched by the exchange of the bound nucleotide
from GDP to GTP or vice versa. The second is that GDP/GTP exchange is regulated by a guanine nucleotide exchange factor,
which stabilizes a GTPase conformation with low nucleotide afﬁnity. Since, however, recent biochemical and structural data
seem to contradict this view, we present a generalized scheme for GTPase action. This novel ansatz accounts for those
important cases when conformational switching in addition to guanine nucleotide exchange requires the presence of cofactors,
and gives a more nuanced picture of how the nucleotide exchange is regulated. The scheme is also used to discuss some
problems of interpretation that may arise when guanine nucleotide exchange mechanisms are inferred from experiments with
analogs of GTP, like GDPNP, GDPCP, and GDP g S.
A BRIEF INTRODUCTION TO THE
GTPASE FAMILY
Small GTPases form a superfamily of regulatory GTP hy-
drolases that are involved in core cellular processes such as
messenger RNA (mRNA) translation, signal transduction,
light perception, and intracellular trafﬁcking (for reviews, see
Sprang (1) and Bourne (2)). The GTPases oscillate between
their GTP- and GDP-bound states via precisely regulated
cycles of GTP hydrolysis and exchange of GDP for GTP. The
factors that stimulate the hydrolytic activity and the GDP/
GTP exchange of a GTPase are commonly referred to as the
GTPase activating protein (GAP) (for a review, see Scheffzek
and Ahmadian (3)) and the guanine exchange factor (GEF)
(see Sprang (4)), respectively.
During the last 30 years, nucleotide hydrolysis and ex-
change on GTPases have been extensively studied with bio-
chemical and structural methods.Many x-ray crystal structures
are now available for GTPases in the apo-state, in complex
with GDP, GTP, the non hydrolysable GDPNP or GDPCP
analogs or the slowly hydrolysable GTP g S analog. In GDPNP
and GDPCP, the oxygen atom bridging the b- and g-phos-
phates of GTP is substituted by an N or a C atom, respectively.
In terms of bond angles and bond lengths, GDPNP is more
similar to GTP than GDPCP. In GTP g S, one of the oxygen
atoms at the g -phosphate of GTP is substituted by a sulfur
atom.
The GTP-binding domains in the GTPase family have
similar sequences and overall structures, and ﬁve structural
motifs involved in nucleotide binding have been identiﬁed
(Fig. 1). The P-loop (Walker A), NKXD, and SAL motifs
confer nonspeciﬁc GTPase binding to GTP and GDP. The
switch I (effector) and switch II (Walker B) loops allow the
GTPase to discriminate between GTP and GDP, and are thus
essential for the conformational switches at the heart of
GTPase function (1).
The P-loop motif has the consensus sequence
(G/A)XXXXGK(S/T), and binds strongly to the a- and
b-phosphates of GDP and GTP. The NKXD motif, aided by
the SAL motif, binds strongly to the guanine moiety and the
ribose ring. Switch I normally contains a speciﬁc threonine,
sometimes replaced by a serine, which coordinates anMg21 ion
in a manner determined by the identity of the GTPase bound
guanine nucleotide. The role of the threonine (or serine) is either
to promote selective GTPase binding to GTP in relation to GDP
or to prevent premature hydrolysis of the GTPase-bound GTP
molecule (1).
Switch II accommodates the g-phosphate of GTP and is,
together with a semiconserved residue that frequently is Gln
and sometimes His, essential for the GTP hydrolysis reaction
(1,5). Switch II often undergoes large rearrangements when
GTP replaces GDP on the GTPase (Fig. 1) (1,6–8). These two
conformations are often referred to as the GDP- and GTP-
bound forms of the GTPase. Accordingly, switch II has been
implicated as a major determinant of the overall changes in
GTPase conformation in response to GTP hydrolysis or
guanine nucleotide exchange (1), as veriﬁed by crystal
structures of several GTPases in complex with either GDP
or GDPNP, like p21 Ras (9,10), Ga (11,12), SelB (13), and
EF-Tu (6–8).
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According to the classical view, a GTPase should be in the
active GTP conformation when bound to GTP and in a
structurally distinct GDP conformation when bound to GDP.
However, the GDP and GDPNP bound forms of several re-
cently determined X-ray crystal structures of GTPases are
virtually identical (14–16). This aberration from the classical
view led to the suggestion that these GTPases must have a
mode of action distinct from that of their classical counter-
parts (14). There is, as will be described in what follows,
another explanation, which does not invoke a principally
different mechanism for the seemingly deviating GTPases,
but integrates them in a uniﬁed view of GTPase action. In
brief, this is done quantifying the classical view of GTPase
action starting from two simple questions: i), what is equi-
librium constant between the GTP favored (T form) and the
GDP favored (D form) conformations of a GTPase in the
absence of guanine nucleotides, free or in complex with other
ligands; and ii), howmuch better does GTP bind to the T form
than to theD form and howmuch better does GDP bind to the
D form than to the T form? These answers together with
thermodynamic theory are then used to account for hitherto
unexplained experimental observations within an extended
framework of classical GTPase action and to predict the
outcome of new experiments.
RAPID GUANINE NUCLEOTIDE EXCHANGE
AND THEREAFTER
Nucleotide exchange on a GTPase, i.e., dissociation of GDP
and association of GTP, is often catalyzed by GDP/GTP
exchange factors (GEFs). The GEF concept originates in
early reports on the p21 Ras GTPase (reviewed by Bourne
(17)). For some GTPases that return GDP-bound to the free
state after GTP hydrolysis, the rate constant for GDP disso-
ciation is very small and potentially inhibitory for their rapid
cycling back to their active state. A well-known example is
the working cycle of elongation factor Tu (EF-Tu), which
delivers aminoacyl-tRNA to the mRNA programmed ribo-
some in ‘‘ternary’’ complex with GTP (18). After delivery of
aminoacyl-tRNA to the ribosome, EF-Tu returns to the free
state in complex with GDP. The average time for spontane-
ous dissociation of GDP is ;100 s and the cycling time for
EF-Tu in the living cell is ;1 s. However, rapid cycling of
EF-Tu back to the GTP-bound state is made possible by the
presence of the GEF elongation factor Ts (EF-Ts), present in
the cell at a concentration much smaller than that of EF-Tu
(19). When EF-Ts associate with EF-TuGDP, it brings EF-
Tu to a conformation with low guanine nucleotide afﬁnity
and evokes rapid dissociation of GDP (20–22).
The structural corollary to these events is a rearrangement
in the nucleotide-binding pocket of EF-Tu, affecting the
DXXG motif and the following switch II loop (see Fig. 3 and
Cherﬁls and Chardin (23) for a review). The aspartate in
DXXG is, ﬁrst, rearranged to destabilize its interaction with
those water molecules that coordinate an Mg21 ion, which is
a major determinant of the afﬁnity of the GTPase to guanine
nucleotides. Second, the rearrangement destabilizes the in-
teraction between the aspartate and the lysine in the P-loop,
thereby removing an anchor point for nucleotide binding and
thus reducing the afﬁnity of the GTPase to guanine nucleo-
tides (24–26). When the eukaryote homolog eEF1A of the
bacterial EF-Tu binds to GEF eEF1B, an additional structural
feature is that a lysine residue from eEF1Ba subunit interacts
repulsively with the b-phosphate of the guanine nucleotide
and thereby actively ejects it (27). A similar catalysis of GDP
to GTP is performed by GRF1 on p21 Ras (17). The bacterial
GTPase RF3, which recycles class-1 release factors after
termination of protein synthesis, is a particularly interesting
example. Here, the GEF is the ribosome itself, stalled at a
stop codon and in complex with a class-1 release factor (28).
Sometimes, the GEFs discussed here are referred to as
guanine nucleotide dissociation stimulators (GDS) (29–31), a
name better adapted to their actual function (Fig. 2). However,
even if rapid GDP dissociation and GTP binding occur spon-
taneously or are catalyzed by a GDS (GEF), this is just one part
of guanine nucleotide exchange and conformational switching
of a GTPase. For instance, EF-Tu binds GDP with orders-
FIGURE 1 D and T structures of the GTPase. A cartoon
representation of conserved G-protein motifs in EF-T
complexed with GDPNP (Protein Data Bank (PDB) entry
1TTT) (panel A), which is stabilized by tRNA binding in
vivo, and GDP (PDB entry 1TUI) (panel B). Color code:
P-loop (red), switch I and II (chartreuse and purple blue,
respectively), the NKXD motif (yellow), and the SAL motif
(magenta). The G domain is shown in teal. The largest
conformational rearrangements observed between the
GDPNP and GDP conformations in the nucleotide vicinity
are located in the switch regions.
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of-magnitude larger afﬁnity than GTP (32,33), meaning that
even residual amounts of GDP in the cytoplasm will prevent
formation ofGTP-boundEF-Tu. In fact, extensive exchange of
GDP to GTP on EF-Tu requires the presence of yet another
ligand, i.e., which binds tightly to the GTP-favoring state sta-
bilizing it in preference to the GDP-favoring state.When eRF1
binds to the GTPase eRF3, the afﬁnity to GTP of the latter is
greatly increased (34–37). When, ﬁnally, the translocation
GTPase EF-G binds to a naked or pretranslocation ribosome,
its afﬁnity toGDPNP increasesgreatly (38,39) and it undergoes
a large conformational change (40), never observed for freeEF-
G. The ADP-ribosylation factor, regulating intracellular traf-
ﬁcking, only bindsGTPwhen in complexwith its effector (41),
in analogy to the high GTP-afﬁnity of EF-Tu, which requires
the presence of aminoacyl-tRNA.
Three previously unaccounted features of GTPase action
are hidden among these examples. The ﬁrst concerns the
equilibrium afﬁnities of a GTPase to GDP and GTP and how
these afﬁnities depend on other ligands or cofactors. The
second concerns the propensity of a GTPase to switch con-
formation upon guanine nucleotide exchange, and how this
propensity is modulated by cofactors, other than the guanine
nucleotides. The third concerns how chemical differences
between GTP and its analogs affect nucleotide binding and
the propensity of a GTPase to switch conformation. In the
next section, we therefore discuss an equilibrium scheme for
GTPase action, which accounts for their propensity to bind
GTP in the presence of signiﬁcant amounts of GDP in the
cell, their propensity to switch conformation upon guanine
nucleotide exchange, the effects on nucleotide binding and
conformational switching by replacing GTP with its analogs,
and the effects of ligands, other than GDP and GTP, on nu-
cleotide binding and conformational switching.
EQUILIBRIUM SCHEME FOR GUANINE
NUCLEOTIDE BINDING AND CONFORMATIONAL
SWITCHING OF GTPASES
The basis of our analysis of guanine nucleotide binding
to GTPases and their propensity to switch conformation
upon guanine nucleotide exchange is this scheme with a
GTP-favoring conformation, T, and a GDP-favoring con-
formation, D:
D  GDP ! K0=‘GDP T  GDP
K
GDP
D Y[ K
GDP
T Y[
D 
K0
T
K
GTP
D Y[ K
GTP
T Y[
D  GTP ! K0 ‘GTP T  GTP: (1)
D and T are the nucleotide-free D and T conformations of
the GTPase, respectively. Their equilibrium concentrations are
related through [T]¼ K0[D].DGDP is theD form in complex
with GDP (dissociation constant KGDPD ), TGDP is the T form
in complex with GDP (dissociation constant KGDPT ), DGTP is
theD form in complex with GTP (dissociation constantKGTPD ),
and TGTP is the T form in complex with GTP (dissociation
constant KGTPT ). This scheme deviates from standard treat-
ments, in that it focuses on the GTP favoring the T confor-
mation and the GDP favoring the D conformation of the
GTPase, rather than on its GTP- and GDP-bound states.
The parameters ‘GDP and ‘GTP are related to the equilib-
rium constants in Scheme 1 by detailed balance (42):
‘
GTP ¼ K
GTP
D
K
GTP
T
; ‘
GDP ¼ K
GDP
T
K
GDP
D
: (2)
Normally, GTP and GDP have strong preferences for the T
and D forms of the GTPase, respectively, implying that both
‘GTP and ‘GDP are much larger than one. In standard exper-
iments to determine equilibrium constants for the binding of
GDP or GTP to a GTPase (18,39,43), one always estimates
the effective or compounded (equilibrium) dissociation con-
stants KGDPeff or K
GTP
eff ; respectively, reﬂecting the equilibrium
mixture of theD and T forms of the GTPase. Accordingly, the
two effective dissociation constants are operationally deﬁned
by the relations
ð½D1 ½TÞ½GDP
KGDPeff
¼ ð½D  GDP1 ½T  GDPÞ;
ð½D1 ½TÞ½GTP
K
GTP
eff
¼ ð½D  GTP1 ½T  GTPÞ (3)
and can therefore be expressed in terms of the parameters in
Scheme 1 through
FIGURE 2 Uniﬁed model for GTPase-bound nucleotide exchange regu-
lation. After GTP hydrolysis in a GTPase, its reactivation requires dissoci-
ation of GDP and binding of a new GTP molecule. There are two types of
GDP/GTP exchange factors (GEF). The guanine nucleotide dissociation
stimulator (GDS) increases the rate of GDP dissociation by transiently
stabilizing a conformation of the GTPase with small afﬁnity to nucleotides.
GTP binding may subsequently be stabilized by the GTP stabilizing factor
(GSF), which shifts the equilibrium of the apo-form of the GTPase from the
D toward the T conformation. In the case of EF-Tu, elongation factor EF-Ts
acts as GDS, accelerating the rate of GDP/GTP exchange. However, free
EF-Tu has about two orders of magnitude higher afﬁnity to GDP than to
GTP. Aminoacyl-tRNA greatly increases the afﬁnity of EF-Tu to GTP,
thereby acting as the GSF. Formation of the EF-TuGTPaminoacyl-tRNA
complex greatly favors GTP binding to the factor.
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KGDPeff ¼
K
GDP
D ‘
GDPð11 1=K0Þ
11 ‘GDP=K0
;
KGTPeff ¼
K
GTP
T ‘
GTPð11K0Þ
11 ‘GTPK0
: (4)
The equilibrium probabilities P(GTP), P(GDP), or P(0) that
the GTPase is bound to a GTP molecule, a GDP molecule, or
is free, respectively, are related to the effective dissociation
constants in Eqs. 3 and 4 through
PðGTPÞ ¼ ½GTP=K
GTP
eff
11 ½GTP=KGTPeff 1 ½GDP=KGDPeff
;
PðGDPÞ ¼ ½GDP=K
GDP
eff
11 ½GTP=KGTPeff 1 ½GDP=KGDPeff
;
Pð0Þ ¼ 1
11 ½GTP=KGTPeff 1 ½GDP=KGDPeff
(5)
Accordingly, the overall equilibrium probability, P(T), that
the GTPase is in the T form is determined by the probabilities
in Eq 5 and on the conditional probabilities PðTjGTP),
PðTjGDPÞ; and PðTj0Þ that the GTP-bound, GDP-bound,
and free GTPase, respectively, are in the T form, i.e.,
PðTÞ ¼ PðTjGTPÞPðGTPÞ1PðTjGDPÞPðGDPÞ1PðTj0ÞPð0Þ:
(6)
The conditional probabilities in Eq. 6 are obtained by consid-
ering the special cases when the GTPase is populating only the
lowest, only the highest, and only the middle row in Scheme 1,
respectively:
PðTjGTPÞ ¼ ‘
GTP
K0
‘
GTP
K01 1
;
PðTjGDPÞ ¼ K0
‘
GDP1K0
;
PðTj0Þ ¼ K0
11K0
: (7)
From this follows that a GDP-bound GTPase is preferentially in
theD formwhenK0  ‘GDP; a guanine nucleotide-free GTPase
is preferentially in the D form when K0  1; and a GTP-bound
GTPase is preferentially in the T form when ‘GTPK0  1:
However, when K0 is sufﬁciently small, it may happen that
‘GTPK0  1; although ‘GTP  1; implying that the GTP-bound
GTPase preferentially remains in its inactive D form.
From Eqs. 5–7, we obtain an explicit expression for the
probability PðTÞ that a small GTPase is in the T form:
PðTÞ¼
K0 11
½GTP
K
GTP
T
1
½GDP
‘
GDP
K
GDP
D
 
K0 11
½GTP
K
GTP
T
1
½GDP
‘
GDP
K
GDP
D
 
1 11
½GTP
‘
GTP
K
GTP
T
1
½GDP
K
GDP
D
:
(8)
To illustrate, consider the special but common case that
K0  1; ‘GTP  1; ‘GDP  1 and high concentrations of
guanine nucleotides, so that the concentration of free GTPase
is negligible, where Eq. 8 simpliﬁes to
PðTÞ ¼ 1
11
1
‘
GTP
K0
1a
K
GTP
T
K0K
GDP
D
: (9)
The parameter a is the ratio between the concentrations of
GDP and GTP, which normally is quite small in the cytoplasm
(44). A value much larger than 1 of the third term in the
denominator illustrates the case that although a may be small,
the GTPase is preferentially GDP-bound and therefore inac-
tive. When, in other words, the equilibrium ratio K0 between
the concentrations ½T and ½D of the apo-forms of the GTPase
is very small, then the free GTPase may fail to adopt its active
form either because the presence of GTP is not sufﬁcient to
induce the active conformation or because it remains GDP
bound even when the concentration of GDP is much smaller
than the concentration ofGTP. Aswill be demonstrated below,
both these hitherto unexplained scenarios do occur.
However, the situation may change radically in the pres-
ence of ligands, other than the guanine nucleotides, with
different dissociation constants for the T (KLT) and D forms
(KLD) of the GTPase. The presence of such a ligand on the
GTPase is accounted for by substituting the equilibrium
constant K0 in Scheme 1 with a compounded equilibrium
constant K0L; deﬁned as
K0L ¼ K0 K
L
D
K
L
T
¼ K0‘L: (10)
When the ligand has much higher afﬁnity to the T than to theD
form of the GTPase, it means that ‘L  1: Accordingly,
addition of such a ligand would greatly reduce the second and
third terms of the denominator in Eq. 9 and could thus induce a
full switch from the D to the T form of the GTPase. Examples
of this general principle of GTPase action will be given below.
In many recent experiments on GTPases, GTP has been
replaced by one of its noncleavable or slowly cleavable an-
alogs to avoid premature GTP hydrolysis. To account for
such swaps, the dissociation constants KGTPD ; K
GTP
T ; and their
ratio ‘GTP must be replaced by their analog counterparts, e.g.,
KGDPNPD ; K
GDPNP
T ; and ‘
GDPNP ¼ KGDPNPD =KGDPNPT for the
GDPNP analog of GTP. As will be discussed below, it is
likely that KGDPNPT is larger and ‘
GDPNP is smaller than the
corresponding GTP parameters, which may lead to ambigu-
ous interpretation of experiments.
COFACTOR DEPENDENT GDP TO GTP
EXCHANGE AND CONFORMATIONAL
SWITCHING OF GTPASES
Unconditional conformational switching:
classical GTPases
Here, we will use Scheme 1 to discuss a selected number of
GTPases with respect to their afﬁnities to guanine nucleo-
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tides and their ability to switch conformation upon guanine
nucleotide exchange. We will start with a ‘‘classical’’ trio of
GTPases, with focus on EF-Tu, which are able to switch
conformation without any cofactor and then discuss a number
of ‘‘aberrant’’ GTPases (14), for which conformational
switching requires the presence of auxiliary factors.
The three GTPases EF-Tu, p21 Ras, and SelB may be
considered as classical in the sense that their GDPNP- and
GDP-bound structures are distinct and correspond to their
active and inactive forms, respectively (6,9,10,13). Ras and
SelB have similar afﬁnities to GDP and GTP, whereas EF-Tu
has much smaller afﬁnity to GTP than to GDP (Table 1) (33).
This means that free EF-Tu will preferentially bind to GDP,
even when the cytoplasmic concentration of GDP is much
smaller than that of GTP (44), as explained by Eq. 9 above.
However, the afﬁnity of GTP to EF-Tu in binary complex
with aminoacyl-tRNA is higher than the afﬁnity of GDP to
free EF-Tu (18,45). The fact that EF-Tu in the crystal
switches conformation when GDP is replaced by GDPNP (or
GTP) suggests that the conditional probability PðTjGDPNPÞ
(deﬁned in Eq. 7), that EF-Tu in complex with GDPNP is
in T conformation is close to 1, and hence that ‘GDPNPK0  1.
The fact that EF-Tu binds GDPNP with much lower afﬁnity
than GDP means that KGDPNPeff ; as deﬁned in Eq. 4, is much
larger than KGDPeff : Together with the inequalities K0  1;
‘GDP  1; this amounts to the following two equilibrium
relations:
K
GDP
eff ¼ KGDPD ;
K
GTP
eff ¼ KGTPT =K0: (11)
These relations mean that for free EF-Tu molecules, the
measured dissociation constant, KGDPeff ; for GDP binding is
approximated by the dissociation constant, KGDPD ; for GDP
binding to the D form of EF-Tu. In contrast, the measured
dissociation constant, KGTPeff ; is approximated by the disso-
ciation constant KGTPT for GTP binding to the T form of
EF-Tu, divided by equilibrium constant K0 that relates the
equilibrium concentration of the apo T to the apo D form of
the factor (Scheme 1). When, however, EF-Tu is in the binary
complex with aminoacyl-tRNA, the effective dissociation
constant for GTP binding to the factor is given by
K
GTP
eff ¼ KGTPT ð11K0‘LÞ=K0‘L  KGTPT ; (12)
where ‘L; deﬁned in Eq. 10, reﬂects the very large (32,33)
afﬁnity difference in the binding of aminoacyl-tRNA to the T
and D forms of EF-Tu. Equation 12 clariﬁes how the afﬁnity
of GTP to EF-Tu increases from a small value (large KGTPeff )
for the free factor toward its maximal value (minimal KGTPeff )
by the preference, ‘L; of aminoacyl-tRNA for the T compared
to the D form of EF-Tu. In the case of EF-Tu, aminoacyl-
tRNA also serves as an essential GTP stabilizing factor,
allowing for extensive cellular exchange of GDP for GTP in
the presence of a comparatively low, but signiﬁcant, level of
GDP in the cytoplasm. This can be seen by replacing K0 by
K0‘
L in Eq. 9.
Conditional conformational switching: aberrant
or neoclassical GTPases?
X-ray analysis of crystal forms of the GTPase EF-G, re-
sponsible for tRNA and mRNA translocation during protein
elongation on the ribosome (46), shows that irrespective of
the identity (GDP, GDPNP) or presence of guanine nucleo-
tide, the structure of free EF-G is invariably the same. This
conformation is stabilized by strong electrostatic interaction
between the highly conserved P-loop lysine (Lys-25) and the
DXXG aspartate (Asp-83) (Fig. 3) (16,47–49), similar to a
corresponding electrostatic interaction observed for EF-Tu
when in complex with EF-Ts (24–26). This electrostatic in-
teraction may be responsible for the relatively weak guanine
nucleotide binding that characterizes free EF-G (38,39,50), in
analogy with the weak guanine nucleotide binding that
characterizes EF-Tu in complex with EF-Ts (20,33). Instead
of interacting with the g-phosphate, the DXXG motif in
EF-G is here locked internally onto Lys-25, and therefore
does not stabilize GTP. A similar intramolecular lock has
been observed in the structure of eEF2, which is the eukary-
otic homolog of EF-G (51,52).
Similar results have been obtained for other GTPases in-
volved in ribosome function, i.e., for the archeal initiation
factor IF2/aIF5B (53), eukaryote initiation factor eIF2 g (54),
and the eukaryote termination factor eRF3 (14). In all these
cases, the crystal conformation of the GTPase remains the
same when GDP is swapped for GDPNP, a result so shocking
that Kong and co-workers suggested that eRF3 cannot be a
classical GTPase, but must be operating according to a rad-
ically different principle from the classical picture (14). One
concern here is that GTP analogs such as GDPNP may be
chemically too different from native GTP to induce a con-
formational switch that would occur when GDP is swapped
for native GTP, and this will be further discussed below.
However, in the case of the bacterial translocation factor
EF-G, this is less likely, since small angle x-ray scattering
experiments (55) suggest very similar solution structures for
EF-G in apo form, bound to GDP and bound to GTP. Ac-
cordingly, it may well be that EF-G and the other ‘‘aberrant’’
GTPases enter the ribosome in complex with GTP, but in
their inactive D form, rather than in their active T form
(Scheme 1). If so, this is likely to have functional implica-
tions of considerable interest.
In terms of our equilibrium Scheme 1, the inability of the
free GTPase to switch conformation is equivalent with ful-
ﬁllment of the inequality
‘
GDPNP
K0; ‘
GTP
K0  1; (13)
although the GTP afﬁnity to the free factor is similar to
(50,56) or, in some buffer systems, even larger than the GDP
afﬁnity (Table 1) (50). For these factors, the effective disso-
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TABLE 1 Summary of available structural and biochemical data on the interactions of discussed GTPases with GTP, GDPNP and
GDP nucleotides
GTPase Organism
Afﬁnities to GTP,
GDPNP and GDP
Afﬁnities to
GTP, GDPNP
and GDP in the
presence of the
GSF GEF
D/ T transition
in the complex
with GDPNP
D/ T transition in
the complex with
GDPNP and
GSF GEF
Specialized
GDS GEF
p21 Ras Homo sapiens KD(GTP) ¼ 60 nM
KD(GDP) ¼ 80 nM (74)
Yes (10) GRFI and others
(17)
EF-Tu Escherichia coli KD(GTP) ¼ 60 nM
KD(GDP) ¼ 1 nM (33)
Yes, in the complex
with Phe-tRNA
and kirromycin
(75)
EF-Ts (19)
Thermus aqaticus Yes (7) Yes, in the complex
with Phe-tRNA (8)
EF-Ts
Thermus thermophilus KD(GTP) ¼ 58 nM
KD(GDP) ¼ 1.1 nM (32)
Yes (6) EF-Ts
EF-Tu Saccharomyces cerevisiae
mitohondria
KD(GTP) ¼ 5 mM
KD (GDP) ¼ 25 mM (75)
No (76)
SelB Methanococcus
maripaludis
Yes (13) No
E. coli KD(GTP) ¼ 0.74 mM No
KD(GDP) ¼ 13.4 mM (77)
elF5/lF2 Methanothermobacter
thermautotrophicus
No (15) Yes, in the complex
with the ribosome
No
(78)
Oryctolagus
cuniculus(rabbit)
KD(mant-GTP)  14–18 mM No
KD(mant-GDP)  2.3 mM (79)
E. coli KD(GTP) ¼ 70 mM
KD(GDP) ¼ 8 mM (80)*
alF2g Pyrococcus abyssi No (81) No
Sulfolobus salfataricus KD(GTP) ¼ 0.48 6 0.03 mM In the complex with
aalF2 and balF2
No
KD(GDP) ¼ 0.4 6 0.02 mM (82) KD(GTP) ¼ 0.36 6
0.04 mM
KD(GDP) ¼ 0.39 6
0.03 mM (82)
elF2g Rattus norvegicus KD(GTP) n.d., too unstable
KD(GDP) ¼ 16 6 0.1 mM
(83)
Yes, elF2B (84)
EF-G T. thermophilus No (16)
E. coli KD(GTP)  20 mM
KD(GDP)  40 mM (50)y
Yes, in the complex
with the ribosome
(40)
eRF3 Schizosaccharomyces
pombe
No (14) No
H. sapiens KD(GTP)  200 mM, In the complex
with eRFl:
No
KD(GDPNP) . 160 mM, KD(GTP) 0.7 6
0.2 mM,
KD(GDP) ¼ 1.3 6 0.2 mM,
(35)z
KD(GDPNP) 
200 mM,
KD(GDP) ¼ 1.9 6
0.3 mM, (35)
RF3 E. coli KD(GTP) ¼ 2.5 mM,
KD(GDPNP) ¼ 8.5 mM,
KD(GDP) ¼ 5.3 nM, (28)
Yes, in the complex
with the ribosome
(62)
Yes, the ribosome
(28)
KD values given are effective KD values as measured in the experiment.
*similar results in (73)
ysimilar results in (56)
zsimilar results in (36,37)
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ciation constants for GDP and GTP binding in Eq. 4 can, we
suggest, be approximated as
K
GDP
eff ¼ KGDPD ;
K
GTP
eff ¼ ‘GTPKGTPT : (14)
Although the T forms of these GTPases free in solution have
never been seen, the T forms do emerge in the presence of
speciﬁc cofactors, i.e., eRF1 in the case of eRF3 (35), the
naked or posttermination bacterial ribosome in the case of
EF-G (40), the eukaryotic/bacterial ribosome in the case of
eIF5B/IF2 (53). A particularly interesting case is provided by
the archaean aIF2 and, by inference, the eukaryote eIF2.
These initiation factors, which recruit initiator tRNA to the
small ribosomal subunit (57), consist of three subunits, i.e., in
the archaean case aIF2a; aIF2b; and the GTPase aIF2g.
When GDP is substituted with GDPNP, the structure of
aIF2g alone remains unaltered (54), but it changes from D to
T form when also aIF2a is present (58). Accordingly, we
suggest that although the inequalities in Eq. 13 are valid for
these GTPases alone, the presence of a cofactor in each case
with a binding preference by the factor ‘L to the T over the D
form, the inequality
‘
GDPNP
‘
L
K0  1 (15)
is valid instead, which explains why the aIF2g changes struc-
ture upon the nucleotide switch conditional on the presence
of its cofactor. From Scheme 1, we also predict large in-
creases in the binding afﬁnity for GDPNP (and GTP) for
these GTPases when their cofactors are added, as veriﬁed
by biochemical experiments (18,28,41,45). A logical name
for cofactors that stabilize the GTP conformation (T form
in Scheme 1) of GTPases would be GTP stabilizing factors
(GSF) (Fig. 2).
An interesting case of ligand-induced stabilization also of
the D form of a G-protein is revealed by the crystal structure
of a 1:1:1 complex of Thermus thermophilus EF-Tu with
GDP and the antibiotic aurodox. Although EF-Tu is GDP-
bound, its structure is in the T form (59), as described in their
Abstract: ‘‘GTP complex-like conformation of EF-Tu is
observed, although GDP is bound to the nucleotide-binding
site.’’ Our interpretation of this ﬁnding based on Scheme 1
and Eq. 10 is that aurodox greatly favors the T form of the
factor, and that the afﬁnity of GDP to theD form compared to
the T form is insufﬁcient to counteract the T form-favoring
effect of aurodox.
From considerations presented above we propose that
eRF3, eIF5B/IF2, EF-G, and aIF2g are classical or, if
preferred, neoclassical GTPases. That is, they do have
functionally relevant T forms, albeit emerging in a cofactor-
dependent manner. Further evidence for the classical nature
of these factors is provided by sequence data, revealing
identical DXXG sequences in eRF3, eIF5B/IF2, EF-G, and
strong DXXG conservation among small GTPases in general
(60). These conservation features, which reﬂect strong se-
lection pressure in favor of these motifs (61), suggest a uni-
versal mechanism that is shared by all small GTPases, i.e.,
they are all fundamentally classical in a fundamental way.
In this common mechanism, the interactions between the
g-phosphate of GTP and the Mg21 ion with the switch II
DXXG motif, as seen in the classical T form of small
GTPases (1), would be preserved.
The bacterial class 2 release factor RF3, which rapidly
recycles class 1 release factors after termination of protein
synthesis, has a working cycle reminiscent of the cycles of
both EF-Tu and EF-G. The crystal structure of GDP, but not
GDPNP, bound RF3 has been determined (62). The spon-
taneous release of GDP from the free factor (28) is almost as
slow as for EF-Tu (19), but its GEF or, preferably, GDS, is
part of its target molecule, i.e., the bacterial ribosome in
complex with a class 1 release factor and with a peptidyl-
tRNA or a deacylated tRNA in the ribosomal P site (28,63).
In contrast, stable binding of GTP requires removal of
the peptide from the peptidyl-tRNA, allowing the ribosome
to adopt its ratcheted conformation, in which the ribosomal
subunits have undergone a relative rotation (40,64) bringing
the deacylated tRNA, originally in the full P site (P/P site),
to a hybrid P/E site (62). Accordingly, the latter ribo-
some complex is the GTP stabilizing factor for RF3, so
that different states of the ribosome act as GDS and GSF for
RF3.
This mode of operation of RF3 is principally similar to the
GTPase ‘‘channeling’’, previously identiﬁed in eukaryote
systems (42), meaning that reaction intermediates are moved
from complex to complex without entering the free state (for
a review, see Marintchev and Wagner (65)). For instance,
during GDP/GTP exchange on the eukaryotic elongation
factor eEF1A, an analog EF-Tu, it forms a stable complex
with eEF1B (the ‘‘GDS’’), which leads to rapid dissociation
of GDP. In the next step, aminoacyl-tRNA binds to eEF1A
and displaces eEF1B (66,67), thereby moving the GTPase
directly from its complex with eEF1B to its GTP-stabilized
complex with aminoacyl-tRNA (the ‘‘GSF’’). A similar
strategy has been proposed for GDP/GTP exchange on eIF2
(68), with eIF2B, a homolog of eEF1B, and initiator tRNA
playing the roles of GDS and GSF, respectively.
GTP IS DIFFERENT FROM ITS
NONHYDROLYSABLE ANALOGS: ARTIFACTS
AND AMBIGUITIES
Hydrolysis deﬁcient analogs of GTP are often used to freeze
GTPases in the step just preceding GTP hydrolysis. This is a
particularly useful approach when the GTP-bound T form
(Scheme 1) is the active molecule in the cycle of the GTPase.
However, it has recently been suggested that the active part of
the GTPase cycle does not end until inorganic phosphate is
released from the GTPase in a GAP-induced reaction. In the
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cases of EF-G (69) and eIF2 (70), it is GAP-induced release
of inorganic phosphate, rather than GTP hydrolysis, that
deﬁnes the end of the active part of the action cycle. Fur-
thermore, Kotting and colleagues (71) used time-resolved
Fourier transform infrared spectroscopy to demonstrate that
GTP binding to p21 Ras results in a reaction intermediate
after GTP hydrolysis in which H2PO

4 is hydrogen-bonded to
an eclipsed conformation of the GDP b-phosphate. From this
high standard free energy intermediate, H2PO

4 may either
reform GTP or dissociate in a step that is rate limiting for the
complete GTPase reaction. In these and similar cases, where
the most important action of the GTPase is carried out after
GTP hydrolysis and before phosphate release, analysis of the
GTPase frozen in a prehydrolytic step in complex with a GTP
analog would miss essential parts of the action cycle.
Another aspect of the replacement of GTP with one of its
analogs is that the structures of a GTPase in complex with
GTP and a GTP analog may be different. Some GTPases
have smaller afﬁnity to GDPNP than to GTP, as exempliﬁed
by EF-G (50), RF3 (28), and eRF3 (35). This suggests that
also the ratio ‘GDPNP; reﬂecting the higher afﬁnity of GDPNP
binding to the T than to the D form of the GTPase as deﬁned
earlier in this article, may be much smaller than the corre-
sponding ratio, ‘GTP; for native GTP. We have observed that
the afﬁnity of GTP, but not GDPNP, to eRF3 is greatly in-
creased by the presence of eRF1 (Table 1) (35). In terms of
FIGURE 3 Structural elements involved in GDP
ejection and consequent GTP binding: response on
GSF and GDS association with the GTPase. Car-
toon representations of EF-Tu (PDB entry 1TTT)
and EF-G (PDB entry 2BV3) in complex with
GDPNP (panels A and B, respectively). GDP-bound
structures of EF-Tu (PDB entry 1TUI) and EF-G
(PDB entry 1DAR) are presented in panels C andD,
respectively. Panels E and F show EF-Tu in com-
plex with EF-Ts (PDB entry 1EFU) and the apo-
form of EF-G (PDB entry 1ELO), respectively.
Color codes are the same as in Fig. 1.
Nucleotide Binding to GTPases 1711
Biophysical Journal 95(4) 1704–1715
our analysis, this means that the effective dissociation con-
stant for GTP binding to eRF3, as deﬁned in Eq. 4, decreases
by the addition of eRF1:
K
GTP
eff ðeRF1Þ ¼
K
GTP
T ‘
GTPð11K0Þ
11 ‘GTPK0

K
GTP
eff ð1eRF1Þ ¼
K
GTP
T ‘
GTPð11K0‘eRF1Þ
11 ‘GTPK0‘
eRF1 : (16)
Here, ‘eRF1 is deﬁned according to Eq. 10 as the ratio between
the dissociation constants for eRF1 binding to the D and T
forms of eRF3. This inequality is readily explained if
‘GTPK0  1 and ‘GTPK0‘eRF1  1; so that the following
approximations are valid:
KGTPeff ðeRF1Þ  KGTPT ‘GTP  KGTPeff ð1eRF1Þ 
K
GTP
T
K0‘
eRF1:
(17)
The unchanged afﬁnity of GDPNP to eRF3 upon eRF1
addition, means that
K
GDPNP
eff ðeRF1Þ ¼
KGDPNPT ‘
GDPNPð11K0Þ
11 ‘GDPNPK0

K
GDPNP
eff ð1eRF1Þ ¼
K
GDPNP
T ‘
GDPNPð11K0‘eRF1Þ
11 ‘GDPNPK0‘
eRF1 : (18)
Here, by hypothesis, ‘GDPNPK0  1 and ‘GDPNPK0‘eRF1  1;
so that the following approximations are valid:
K
GDPNP
eff ðeRF1Þ  KGDPNPT ‘GDPNP  KGDPNPeff ð1eRF1Þ: (19)
According to Eq. 7, this explanation also implies that eRF3
switches from the D to the T conformation when GDP is
swapped for GTP in the presence (‘GTPK0‘
eRF1  1Þ but not
absence (‘GTPK0  1) of eRF1. It also implies that eRF3
switches from the D to the T conformation when GDP is
swapped for GDPNP neither in the presence
(‘GDPNPK0‘
eRF1  1) nor in the absence (‘GDPNPK0  1) of
eRF1.
CONCLUSIONS
At the heart of this work is an equilibrium scheme (Scheme 1)
of the conformational propensities of GTPases to be in their
inactive D and active T forms. These propensities are deter-
mined by the free concentrations of GDP and GTP, the
propensity of the GTPase to be in either of its forms when it is
bound to GDP, GTP, or free from nucleotide and the presence
of cofactors with selective binding to the D and T forms. The
scheme also quantiﬁes how differences between GTP on one
hand and analogs of GTP on the other may affect the pro-
pensity of conformational switching of free as well as co-
factor-bound GTPases.
Despite its simplicity, the framework of Scheme 1 and
Eq. 10 may clarify a number of hitherto mystifying obser-
vations. It suggests, for instance, why bacterial elongation
factor EF-G remains in the D form, when its bound nucleo-
tide is changed from GDP to the GTP analog GDPNP (16) or
even to native GTP (55) and why the T form of EF-G is only
seen in complex with the ribosome (40). It explains in a very
similar way why the GTPase eIF5B, when GTP bound, has
much higher afﬁnity to the ribosome than when GDP-bound
((72) and J. Lorsch, personal communication), although the
GDP and GTP binding forms of free eIF5B are very similar
(53). The explanation, we propose, is that free eIF5B, like
free EF-G, remains in its inactive D form even when in
complex with GTP, but switches conformation in the pres-
ence of the ribosome, which, by hypothesis, has higher af-
ﬁnity to the T than to the D form of eIF5B. It accounts for the
observation that the crystal structures of GDP- and GDPNP-
bound eRF3 are virtually identical (14) without the need to
invoke an aberrant, nonclassical mode of operation of this
GTPase. It also suggests a simple explanation for why the
afﬁnity of GTP to eRF3 increases greatly upon addition of
eRF1, whereas the afﬁnity of GDPNP remains virtually un-
changed upon eRF1 addition (35).
In all those cases where our theory suggests that the T form
of a G-protein will become dominant only in the presence
also of other ligands than GTP or when the GTPase is target
bound, its prediction of a ‘‘classical’’ mode of operation can
be directly tested by high-resolution crystal structures of
these complexes. The cryo-EM structure of EF-G in complex
with GDPNP on the ribosome is in line with our theory, since
it is very different from the free forms of GDPNP- or GTP-
bound EF-G; but high-resolution structures are likely to
provide more deﬁnitive answers.
Another way to test our predictions would be to identify
the coexistence of GTP-bound D and T forms of a G-protein.
One candidate is elongation factor G in complex with GTP,
which may be shifted sufﬁciently much toward the T form, to
allow detection of the coexistence of a major D form and a
minor T form. One way to do this experimentally would be to
use ﬂuorescence-labeled EF-G and single molecule detection
techniques to determine the equilibrium relation and transi-
tion rates between the two forms. Similarly, GTP-bound
EF-Tu may exist in a major T and a minor D form, and the
predicted coexistence of the two forms may be identiﬁed by
ﬂuorescence techniques as in the case of EF-G.
Yet another way of testing the theory also relates to the
absence of a T form for a free G-protein, such as EF-G, eRF3,
etc. This may either mean that the free T and D forms are so
similar, that they cannot be distinguished by crystallography,
or that the GTP-bound free factor remains in the D form, as
suggested in this work. If the latter supposition is true, then,
e.g., EF-G would enter the pretranslocation ribosome in the
same D form, whether GTP or GDP bound, and thus with the
same kinetics. When the factor enters GTP-bound, it would
subsequently switch conformation to its T form, which could
be detected by ﬂuorescence after suitable labeling of the
factor. If, in contrast, the factor is GDP-bound, it would re-
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main in that form also when ribosome bound. If the former
supposition is true, then the factor would be in the T form
already in the free state, and would enter the ribosome with
different kinetics than the GDP-bound factor in the D form.
Scheme 1 is based on equilibrium thermodynamics and is,
essentially, a concise way to keep track of the difference in
standard free energy of the ground states of theD and T forms
of GTPases as they pass through the different steps of their
cycles. Although the theory in its current form does not
predict the rate constants of G-protein cycles, it provides a
conceptual framework on which all kinetic considerations
have to be based. The scheme also offers a convenient way to
classify GTPases according to differences in their modes of
operation, i.e., when they switch from theirD to their T forms
and back again.
Further development of this analysis to account also for the
kinetics of GTPase action will greatly beneﬁt from atomic
resolution structures of translational GTPases in ribosomal
complexes. It is, in particular, the extensive integration of
kinetic and structural studies of GTPases that will allow for
generalizations at a deeper level of the modes of action of
these interesting enzymes.
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